← Open Payments lookup

SAMRA AMAN: Open Payments

NPI 1417677238 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$556 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $215 · 2025 $556

Food & beverage: $556
CompanyPaymentsAmount
PFIZER INC.5$117
ABBVIE INC.5$101
Novo Nordisk Inc4$73
Lilly USA, LLC4$71
AstraZeneca Pharmaceuticals LP2$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
Novartis Pharmaceuticals Corporation1$24
SANOFI-AVENTIS U.S. LLC1$22
Axsome Therapeutics, Inc.1$22
Dynavax Technologies Corporation1$19

Products named: PREVNAR 20, Wegovy, MOUNJARO, QULIPTA, UBRELVY, AIRSUPRA, XIFAXAN, LEQVIO.

Industry payments across TX — which companies pay providers there.